Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...

FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products ...

The Food and Drug Administration (FDA) announced on Thursday that it authorized the marketing of Zyn nicotine pouches but ...

The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...

The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs.

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive ...

The agency finds Zyn’s benefit as a safer alternative for adult cigarette smokers outweighs its risk to young people.

The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.

The Food and Drug Administration has authorized the sale of Zyn nicotine pouches as a way to help smokers kick the habit. FOX ...

Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...

The Food and Drug Administration has authorized the sales of 20 types of ZYN nicotine pouches amid concerns about children ...